Abstract
Thrombotic microangiopathy is a well-known heterogeneous disorder that occurs as a complication of allogenic bone marrow transplantation (BMT). We evaluated 12 consecutive patients receiving HLA-matched unrelated BMT and 12 consecutive recipients of HLA-identical related BMT for the development of bone marrow transplantation-associated thrombotic microangiopathy (BMT–TM) on days 30 and 60 following BMT. A diagnosis was made in four of 12 (33.3%) unrelated compared to none of 12 (0%) HLA-identical cases. Levels of serum lactic dehydrogenase (LDH), fibrin degraded products (FDP) and de novo thrombocytopenia were elevated in eight of 12 patients (66.7%) receiving unrelated donor BMT, and none of the patients receiving related donor BMT. Our findings suggest clinical or subclinical microangiopathic changes may occur frequently in unrelated donor BMT. FDP elevation is possibly an important marker of microangiopathic changes as early complications of BMT.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Natazuka, T., Kajimoto, K., Ogawa, R. et al. Coagulation abnormalities and thrombotic microangiopathy following bone marrow transplantation from HLA-matched unrelated donors in patients with hematological malignancies. Bone Marrow Transplant 21, 815–819 (1998). https://doi.org/10.1038/sj.bmt.1701169
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1701169
Keywords
This article is cited by
-
Life-threatening hemolytic-uremic syndrome treated with rituximab in an allogeneic bone marrow transplant recipient
Bone Marrow Transplantation (2007)
-
Transplant-associated microangiopathy (TAM) in recipients of allogeneic hematopoietic stem cell transplants
Bone Marrow Transplantation (2005)
-
Renal function following hematological stem cell transplantation in childhood
Pediatric Nephrology (2003)
-
Clinical Significance of Fragmented Red Cells after Allogeneic Bone Marrow Transplantation
International Journal of Hematology (2003)
-
Impact of thrombotic thrombocytopenic purpura on leukemic children undergoing bone marrow transplantation
Bone Marrow Transplantation (2000)